Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor

Experimental Animals

Volumn 64, Issue 2, 2015, Pages 109-119

  Seno, Akimasa ^a,b   Maruhashi, Takumi ^a,b   Kaifu, Tomonori ^a,b,c   Yabe, Rikio ^a,b   Fujikado, Noriyuki ^a   Ma, Guangyu ^a   Ikarashi, Tetsuro ^d   Kakuta, Shigeru ^d   Iwakura, Yoichiro ^a,b,c,e  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e CHIBA UNIVERSITY   (Japan)

Author keywords

C type lectin receptor; Dendritic cell immunoreceptor; Experimental autoimmune encephalomyelitis; Multiple sclerosis

Indexed keywords

B7 ANTIGEN; CD11 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; DENDRITIC CELL IMMUNORECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INHIBITORY C TYPE LECTIN RECEPTOR; INTERLEUKIN 17; LECTIN RECEPTOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UNCLASSIFIED DRUG; DENDRITIC CELL IMMUNOACTIVATING RECEPTOR, MOUSE; IMMUNOGLOBULIN RECEPTOR; LECTIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL INFILTRATION; CELL PROLIFERATION; DEMYELINATION; ENTHESITIS; FLOW CYTOMETRY; HISTOLOGY; HOMEOSTASIS; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; IMMUNOREGULATION; LYMPH NODE CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; SIALOADENITIS; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CHEMISTRY; DEMYELINATING DISEASE; DENDRITIC CELL; DISEASE COURSE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGY; LYMPH NODE; MULTIPLE SCLEROSIS; PATHOLOGY; SPINAL CORD; TRANSGENIC MOUSE;

MUS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DEMYELINATING DISEASES; DENDRITIC CELLS; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; LECTINS, C-TYPE; LYMPH NODES; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIPLE SCLEROSIS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 84929320798     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.14-0079     Document Type: Article

References (46)

1. Bailey, S.L., Schreiner, B., McMahon, E.J., and Miller, S.D. 2007. CNS myeloid DCs presenting endogenous myelin peptides ‘preferentially’ polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 8: 172–180. [Medline] [Cross- Ref]
2. Bates, E.E., Fournier, N., Garcia, E., Valladeau, J., Durand, I., Pin, J.J., Zurawski, S.M., Patel, S., Abrams, J.S., Lebecque, S., Garrone, P., and Saeland, S. 1999. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 163: 1973–1983. [Medline]
3. Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E., and Carton, H. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol. 140: 1506–1510. [Medline]
4. Bläss, S., Haferkamp, C., Specker, C., Schwochau, M., Schneider, M., and Schneider, E.M. 1997. Rheumatoid arthritis: autoreactive T cells recognising a novel 68k autoantigen. Ann. Rheum. Dis. 56: 317–322. [Medline] [CrossRef]
5. Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., and Becher, B. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560–567. [Medline] [CrossRef]
6. Comabella, M., Montalban, X., Münz, C., and Lünemann, J.D. 2010. Targeting dendritic cells to treat multiple sclerosis. Nat. Rev. Neurol. 6: 499–507. [Medline]
7. Compston, A. and Coles, A. 2008. Multiple sclerosis. Lancet 372: 1502–1517. [Medline] [CrossRef]
8. Dittel, B.N., Visintin, I., Merchant, R.M., and Janeway, C.A. Jr. 1999. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J. Immunol. 163: 32–39. [Medline]
9. El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.X., Dittel, B.N., and Rostami, A. 2011. The encephalitogenicity of T(H)17 cells is dependent on IL- 1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12: 568–575. [Medline] [CrossRef]
10. Fujikado, N., Saijo, S., and Iwakura, Y. 2006. Identification of arthritis-related gene clusters by microarray analysis of two independent mouse models for rheumatoid arthritis. Arthritis Res. Ther. 8: R100. [Medline] [CrossRef]
11. Fujikado, N., Saijo, S., Yonezawa, T., Shimamori, K., Ishii, A., Sugai, S., Kotaki, H., Sudo, K., Nose, M., and Iwakura, Y. 2008. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 14: 176–180. [Medline] [CrossRef]
12. Furlan, R., Brambilla, E., Ruffini, F., Poliani, P.L., Bergami, A., Marconi, P.C., Franciotta, D.M., Penna, G., Comi, G., Adorini, L., and Martino, G. 2001. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J. Immunol. 167: 1821–1829. [Medline] [CrossRef]
13. Gold, R., Linington, C., and Lassmann, H. 2006. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129: 1953–1971. [Medline] [CrossRef]
14. Goverman, J. 2009. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9: 393–407. [Medline] [CrossRef]
15. Greter, M., Heppner, F.L., Lemos, M.P., Odermatt, B.M., Goebels, N., Laufer, T., Noelle, R.J., and Becher, B. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11: 328–334. [Medline] [CrossRef]
16. Hauser, S.L., Waubant, E., Arnold, D.L., Vollmer, T., Antel, J., Fox, R.J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., Langer-Gould, A., Smith, C.H., and HERMES Trial Group 2008. B-cell depletion with rituximab in relapsingremitting multiple sclerosis. N. Engl. J. Med. 358: 676–688. [Medline] [CrossRef]
17. Hoet, R.M., Boerbooms, A.M., Arends, M., Ruiter, D.J., and van Venrooij, W.J. 1991. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin. Ann. Rheum. Dis. 50: 611–618. [Medline] [CrossRef]
18. Huang, D.R., Wang, J., Kivisakk, P., Rollins, B.J., and Ransohoff, R.M. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193: 713–726. [Medline] [CrossRef]
19. Kapsenberg, M.L. 2003. Dendritic-cell control of pathogendriven T-cell polarization. Nat. Rev. Immunol. 3: 984–993. [Medline] [CrossRef]
20. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., and Iwakura, Y. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566–573. [Medline] [CrossRef]
21. Kroenke, M.A., Carlson, T.J., Andjelkovic, A.V., and Segal, B.M. 2008. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205: 1535–1541. [Medline] [CrossRef]
22. Lackner, K.J., Schlosser, U., Lang, B., and Schmitz, G. 1998. Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera. Br. J. Rheumatol. 37: 1164–1171. [Medline] [CrossRef]
23. Lee, E., Chanamara, S., Pleasure, D., and Soulika, A.M. 2012. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. J. Neuroinflammation 9: 7. [Medline] [CrossRef]
24. Litzenburger, T., Fässler, R., Bauer, J., Lassmann, H., Linington, C., Wekerle, H., and Iglesias, A. 1998. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med. 188: 169–180. [Medline] [CrossRef]
25. Liu, J., Marino, M.W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A.J., Old, L., and Bernard, C.C. 1998. TNF is a potent anti-inflammatory cytokine in autoimmunemediated demyelination. Nat. Med. 4: 78–83. [Medline] [CrossRef]
26. Lund, F.E. and Randall, T.D. 2010. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat. Rev. Immunol. 10: 236–247. [Medline] [CrossRef]
27. Marta, M. 2009. Toll-like receptors in multiple sclerosis mouse experimental models. Ann. N. Y. Acad. Sci. 1173: 458–462. [Medline] [CrossRef]
28. Matsuki, T., Nakae, S., Sudo, K., Horai, R., and Iwakura, Y. 2006. Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Int. Immunol. 18: 399–407. [Medline] [CrossRef]
29. Matsushita, T., Yanaba, K., Bouaziz, J.D., Fujimoto, M., and Tedder, T.F. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420–3430. [Medline]
30. McMahon, E.J., Bailey, S.L., Castenada, C.V., Waldner, H., and Miller, S.D. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11: 335–339. [Medline] [CrossRef]
31. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819–826. [Medline] [CrossRef]
32. Meyer-Wentrup, F., Benitez-Ribas, D., Tacken, P.J., Punt, C.J., Figdor, C.G., de Vries, I.J., and Adema, G.J. 2008. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production. Blood 111: 4245–4253. [Medline] [CrossRef]
33. Meyer-Wentrup, F., Cambi, A., Joosten, B., Looman, M.W., de Vries, I.J., Figdor, C.G., and Adema, G.J. 2009. DCIR is endocytosed into human dendritic cells and inhibits TLR8- mediated cytokine production. J. Leukoc. Biol. 85: 518–525. [Medline] [CrossRef]
34. Mills, K.H. 2011. TLR-dependent T cell activation in autoimmunity. Nat. Rev. Immunol. 11: 807–822. [Medline]
35. Nakae, S., Asano, M., Horai, R., Sakaguchi, N., and Iwakura, Y. 2001. IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J. Immunol. 167: 90–97. [Medline] [CrossRef]
36. Nienhuis, R.L. and Mandema, E. 1964. A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor. Ann. Rheum. Dis. 23: 302–305. [Medline] [CrossRef]
37. Okuda, Y., Okuda, M., and Bernard, C.C. 2002. The suppression of T cell apoptosis influences the severity of disease during the chronic phase but not the recovery from the acute phase of experimental autoimmune encephalomyelitis in mice. J. Neuroimmunol. 131: 115–125. [Medline] [CrossRef]
38. Rao, P. and Segal, B.M. 2004. Experimental autoimmune encephalomyelitis. Methods Mol. Med. 102: 363–375. [Medline]
39. Stromnes, I.M., Cerretti, L.M., Liggitt, D., Harris, R.A., and Goverman, J.M. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 14: 337–342. [Medline] [CrossRef]
40. Stromnes, I.M. and Goverman, J.M. 2006. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1: 1810–1819. [Medline] [CrossRef]
41. Thakker, P., Leach, M.W., Kuang, W., Benoit, S.E., Leonard, J.P., and Marusic, S. 2007. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 178: 2589–2598. [Medline] [CrossRef]
42. Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di Pucchio, T., Connolly, J., Fay, J.W., Pascual, V., Palucka, A.K., and Banchereau, J. 2007. Dendritic cell subsets in health and disease. Immunol. Rev. 219: 118–142. [Medline] [CrossRef]
43. Voorthuis, J.A., Uitdehaag, B.M., De Groot, C.J., Goede, P.H., van der Meide, P.H., and Dijkstra, C.D. 1990. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin. Exp. Immunol. 81: 183–188. [Medline] [CrossRef]
44. Willenborg, D.O., Fordham, S., Bernard, C.C., Cowden, W.B., and Ramshaw, I.A. 1996. IFN-γ plays a critical downregulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157: 3223–3227. [Medline]
45. Yonekawa, A., Saijo, S., Hoshino, Y., Miyake, Y., Ishikawa, E., Suzukawa, M., Inoue, H., Tanaka, M., Yoneyama, M., Oh-Hora, M., Akashi, K., and Yamasaki, S. 2014. Dectin-2 is a direct receptor for mannose-capped lipoarabinomannan of mycobacteria. Immunity. 41: 402–413. [Medline] [CrossRef]
46. Zhou, D., Srivastava, R., Nessler, S., Grummel, V., Sommer, N., Brück, W., Hartung, H.P., Stadelmann, C., and Hemmer, B. 2006. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl. Acad. Sci. USA 103: 19057–19062. [Medline] [CrossRef]